Details for New Drug Application (NDA): 083590
✉ Email this page to a colleague
NDA 083590 describes NAPHAZOLINE HYDROCHLORIDE, which is a drug marketed by Rising and Altaire Pharms Inc and is included in three NDAs. Additional details are available on the NAPHAZOLINE HYDROCHLORIDE profile page.
The generic ingredient in NAPHAZOLINE HYDROCHLORIDE is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
The generic ingredient in NAPHAZOLINE HYDROCHLORIDE is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
Summary for 083590
| Tradename: | NAPHAZOLINE HYDROCHLORIDE |
| Applicant: | Rising |
| Ingredient: | naphazoline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 083590
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
